252 related articles for article (PubMed ID: 34851465)
1. Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients.
Studsgaard A; Clemmensen KØ; Nielsen MS
Graefes Arch Clin Exp Ophthalmol; 2022 May; 260(5):1633-1639. PubMed ID: 34851465
[TBL] [Abstract][Full Text] [Related]
2. Fluocinolone acetonide intravitreal implant (Retisert
Leinonen S; Immonen I; Kotaniemi K
Acta Ophthalmol; 2018 Sep; 96(6):648-651. PubMed ID: 29655222
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal fluocinolone acetonide implant for the treatment of persistent post-surgical cystoid macular edema in vitrectomized eyes.
Miguel-Escuder L; Olate-Pérez Á; Sala-Puigdoners A; Moll-Udina A; Figueras-Roca M; Navarro-Angulo MJ; Adán A; Pelegrín L
Eur J Ophthalmol; 2023 Jan; 33(1):NP23-NP27. PubMed ID: 34836464
[TBL] [Abstract][Full Text] [Related]
4. Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: The PALADIN Study.
Singer MA; Sheth V; Mansour SE; Coughlin B; Gonzalez VH
Ophthalmology; 2022 Jun; 129(6):605-613. PubMed ID: 35063472
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: five-year real-world results.
Dobler E; Mohammed BR; Chavan R; Lip PL; Mitra A; Mushtaq B
Eye (Lond); 2023 Aug; 37(11):2310-2315. PubMed ID: 36513858
[TBL] [Abstract][Full Text] [Related]
6. Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.
Tomkins-Netzer O; Lightman S; Drye L; Kempen J; Holland GN; Rao NA; Stawell RJ; Vitale A; Jabs DA;
Ophthalmology; 2015 Nov; 122(11):2351-9. PubMed ID: 26359188
[TBL] [Abstract][Full Text] [Related]
7. The long-term efficacy and safety of fluocinolone acetonide intravitreal implant 190 μg (ILUVIEN
Panos GD; Arruti N; Patra S
Eur J Ophthalmol; 2021 Mar; 31(2):620-629. PubMed ID: 31906704
[TBL] [Abstract][Full Text] [Related]
8. SUSTAINED-RELEASE LOW-DOSE FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT FOR CHRONIC POSTOPERATIVE CYSTOID MACULAR EDEMA: TWO CASE REPORTS.
Kiernan DF
Retin Cases Brief Rep; 2024 Jul; 18(4):421-427. PubMed ID: 36657153
[TBL] [Abstract][Full Text] [Related]
9. The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema.
Vaz-Pereira S; Castro-de-Sousa JP; Martins D; Prates Canelas J; Reis P; Sampaio A; Urbano H; Kaku P; Nascimento J; Marques-Neves C
Ophthalmic Res; 2020; 63(2):114-121. PubMed ID: 31801148
[TBL] [Abstract][Full Text] [Related]
10. Discontinuous to continuous therapy for persistent diabetic macular edema leads to reduction in treatment frequency.
Adams OE; Schechet SA; Hariprasad SM
Eur J Ophthalmol; 2021 Mar; 31(2):612-619. PubMed ID: 31964171
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic diabetic macular oedema with intravitreal fluocinolone acetonide implant; real-life analysis of outcomes during overall treatment period.
Cox L; Li Y; Fotuhi M; Vermeirsch S; Yeung I; Hamilton RD; Rajendram R; Lukic M
Eur J Ophthalmol; 2022 Nov; 32(6):3629-3636. PubMed ID: 35484812
[TBL] [Abstract][Full Text] [Related]
12. BILATERAL INTRAVITREAL 0.19-MG FLUOCINOLONE ACETONIDE IMPLANT FOR PERSISTENT NONDIABETIC CYSTOID MACULAR EDEMA AFTER VITRECTOMY.
Ong SS; Walter SD; Chen X; Thomas AS; Finn AP; Fekrat S
Retin Cases Brief Rep; 2021 May; 15(3):261-265. PubMed ID: 30015770
[TBL] [Abstract][Full Text] [Related]
13. Twenty-Four Months Follow-Up of Intravitreal Bevacizumab Injection Versus Intravitreal Triamcinolone Acetonide Injection for the Management of Persistent Non-Infectious Uveitic Cystoid Macular Edema.
Lasave AF; Schlaen A; Zeballos DG; Díaz-Llopis M; Couto C; El-Haig WM; Arevalo JF
Ocul Immunol Inflamm; 2019; 27(2):294-302. PubMed ID: 29157128
[TBL] [Abstract][Full Text] [Related]
14. Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years.
Fusi-Rubiano W; Mukherjee C; Lane M; Tsaloumas MD; Glover N; Kidess A; Denniston AK; Palmer HE; Manna A; Morjaria R
BMC Ophthalmol; 2018 Feb; 18(1):62. PubMed ID: 29486754
[TBL] [Abstract][Full Text] [Related]
15. Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)-results from the ILUVIT study.
Deuchler SK; Schubert R; Singh P; Chedid A; Kenikstul N; Scott J; Kohnen T; Ackermann H; Koch F
Graefes Arch Clin Exp Ophthalmol; 2022 Aug; 260(8):2537-2547. PubMed ID: 35239010
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal Fluocinolone 0.19mg Implant in the Management of Chronic Non-Infectious Uveitis: 12-Month Outcomes from a Single Tertiary Centre.
Pockar S; Leal I; Chhabra R; Jones NP; Steeples LR
Ocul Immunol Inflamm; 2023 Oct; 31(8):1572-1578. PubMed ID: 34124978
[TBL] [Abstract][Full Text] [Related]
17. Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.
Thorne JE; Sugar EA; Holbrook JT; Burke AE; Altaweel MM; Vitale AT; Acharya NR; Kempen JH; Jabs DA;
Ophthalmology; 2019 Feb; 126(2):283-295. PubMed ID: 30269924
[TBL] [Abstract][Full Text] [Related]
18. Three-year results from the Retro-IDEAL study: Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN
Augustin AJ; Bopp S; Fechner M; Holz F; Sandner D; Winkgen AM; Khoramnia R; Neuhann T; Warscher M; Spitzer M; Sekundo W; Seitz B; Duncker T; Ksinsik C; Höh H; Gentsch D
Eur J Ophthalmol; 2020 Mar; 30(2):382-391. PubMed ID: 30884972
[TBL] [Abstract][Full Text] [Related]
19. Combined Ahmed Glaucoma Valve Placement, Intravitreal Fluocinolone Acetonide Implantation and Cataract Extraction for Chronic Uveitis.
Chang IT; Gupta D; Slabaugh MA; Vemulakonda GA; Chen PP
J Glaucoma; 2016 Oct; 25(10):842-846. PubMed ID: 27300641
[TBL] [Abstract][Full Text] [Related]
20. Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.
Pessoa B; Coelho J; Correia N; Ferreira N; Beirão M; Meireles A
Ophthalmic Res; 2018; 59(2):68-75. PubMed ID: 29248913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
